Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
Background: Schizophrenia is a costly illness to treat, especially during a time of escalating medicine inflation costs, putting a large economic strain on patients, their families and the community. Treatment, however, can become more affordable through generic substitution. Objective: To determine...
Main Authors: | D. Husselmann, R. Joubert, J.R. Burger, M.S. Lubbe, M. Cockeran |
---|---|
Format: | Article |
Language: | Afrikaans |
Published: |
AOSIS
2016-12-01
|
Series: | Health SA Gesondheid: Journal of Interdisciplinary Health Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1025984816300242 |
Similar Items
-
Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01) -
Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
by: Shrestha R, et al.
Published: (2022-02-01) -
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force
by: Jenna Niyongere, et al.
Published: (2022-06-01) -
Generic policy in Bulgaria: a policy of failure or success?
by: Assena Stoimenova, et al.
Published: (2016-09-01) -
Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)